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Abstract: Particles generated from orthopedic implants
through years of wear play an essential role in the aseptic
loosening of a prosthesis. We have investigated the biocom-
patibility of these orthopedic particles on different osteo-
blast-like cells representative of different stages of osteoblast
maturation. We found the particles induced a caspase-
dependent apoptosis of osteoblasts, with less mature osteo-
blasts being the most susceptible. An analysis of gene ex-
pression was performed on the less mature osteoblasts,
which were in contact with the particles. We found that the
particles had a profound impact on genes that code for in-
flammatory cytokines and genes involved in controlling the
nuclear architecture. Results from this study suggest that the
peri-implant osteolysis after a total joint replacement can be
due in part to a decrease of bone formation and not solely to
an overstimulation of bone resorption as is generally pro-
posed. Development of new drugs that promote normal
bone formation and osteoblast survival would possibly con-
trol peri-implant osteolysis, resulting in a better prognosis
for patients with orthopedic implants. © 2002 Wiley Periodi-
cals, Inc. J Biomed Mater Res 61: 408–420, 2002
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INTRODUCTION
The peri-implant osteolysis after a total joint arthro-
plasty (TJA) is responsible for the majority of ortho-
pedic implant loosening.1 Failure rates of hip arthro-
plasty can exceed 30% after 15 years for patients <50
years old,2 thus, requiring a revision surgery where
the old implant is replaced by a new one. Joint disor-
ders treated with TJA can reasonably be expected to
give satisfactory results for 20 to 30 years with an
initial and revision surgery, but a subsequent proce-
dure cannot be performed in a routine manner. The
current trend is to propose TJA to younger patients
with the caveat that a second surgery is likely to be
required.
The response of cells to particles has been identified
as a major cause of implant loosening.3 These particles
are generated through years of wear. Any of the ma-
terials (metallic, polyethylene, methacrylate, ceramic)
used for the implants or even the calcium phosphate
cement4 can be involved. In cases of loose Ti implants,
the mean concentration of Ti particles retrieved from
tissue surrounding the implants can reach 0.1% of the
dry tissue weight.5
Normal bone function is assured when there is an
equilibrium between bone formation and bone resorp-
tion. Bone resorption has been mostly studied in rela-
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tion with wear particles. Macrophages,6 monocytes,7
or giant cells8 in contact with particles can produce
potent osteolytic factors. Effects of implant particles
on bone formation have been neglected and need to be
explored with a particular emphasis on biocompatibil-
ity testing.
Particles from orthopedic implants have been
shown to influence the expression of some extracellu-
lar matrix proteins in osteoblasts.9 It has been pro-
posed that biocompatibility testing should include ap-
optosis studies.10 Apoptosis, or programmed cell
death, is characterized by the activation of cysteine
proteases called caspases, which cleave proteins es-
sential for the survival of the cell. A member of this
family, caspase-3, has been identified as a key media-
tor of apoptosis of mammalian cells.11 Furthermore,
these caspases activate the endonuclease responsible
for the internucleosomal cleavage of genomic DNA.12
The TUNEL assay (TdT-mediated dUTP-biotin nick
end labeling) can detect the amount of internucleoso-
mal DNA fragments and allow for apoptosis quanti-
fication. Apoptosis quantification is important as it is
the normal fate for the majority of osteoblasts.13 More-
over, an in vitro study showed that Ti particles can
induce apoptosis in osteoblasts.14 The analysis of this
apoptotic pathway and the stimuli that can trigger it
warrants investigation.
The recent advances in molecular biology tech-
niques allow for a more comprehensive study of the
biological alterations induced by wear particles in
physiologically relevant cells such as osteoblasts.15 In
this study, we quantified the apoptotic response to
titanium (Ti) and polymethylmethacrylate (PMMA)
particles in three osteoblast-like cells (human MG-63,
rat osteoblast, and human SaOS-2). These are repre-
sentative of the different maturation stages of the os-
teoblasts. The choice of the particles type was based on
the fact that Ti is a widely used metal for orthopedic
implants and that it generates a large amount of par-
ticles5 that directly interact with osteoblasts during
different stages of their differentiation. PMMA, the
bone cement used to seal orthopedic implants, also
generates particles.16 A gene expression analysis was
performed for the MG-63 osteoblast-like cells while in
contact with these particles.
Our results demonstrate that implant particles in-
duced and promoted apoptosis, especially in less ma-
ture osteoblasts, and that caspase-3 was involved in
this process. The particles had a strong gene expres-
sion effect in osteoblasts with an overall trend favor-
ing bone resorption. These results clearly suggest that
wear particles from orthopedic implants are involved
in the osteolysis not only by favoring bone resorption,
as it is generally accepted, but also by inhibiting bone
formation and interfering with osteoblast prolifera-
tion. Future drugs development aimed to control the
peri-implant osteolysis should enhance the function-
ing and survival of osteoblasts when particles are
present.
MATERIALS AND METHODS
Particles
Commercially pure titanium particles of −325-mesh nomi-
nal diameter were purchased (Aldrich, Milwaukee, WI). The
PMMA particles were a gift from Zimmer (Worthington,
OH). Particle size distributions were performed by laser dif-
fraction using a Malvern MasterSizer equipment. The values
obtained for the different powders are given in Figure 1. The
particles, sterilized by overnight UV irradiation, were mixed
with the culture medium under sterile conditions at a con-
centration of 0.1% (w/w). This concentration can be consid-
ered as representative of the particle concentration found in
the surrounding tissue of loose implant in biopsy study.5
The particle solutions were sonicated for 20 min in a sealed
sterile container to minimize their agglomeration before be-
ing added to the cell culture. Endotoxin contamination of
particles was negligible as tested by limulus assay (QCL-
Figure 1. Frequency plot showing the size distribution of the Ti and PMMA particles used. The plain line represents the
cumulative particle percentage. The size distribution was measured by laser diffraction (Malvern). For the Ti particles, 10%
of the particles had a diameter smaller than 10.7 m, 50% smaller than 30.2 m, and 90% smaller than 176.3 m. For the
PMMA particles, 10% of the particles had a diameter smaller than 8.9 m, 50% smaller than 56.9 m, and 90% smaller than
105.6 m.
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1000 Chromogenic LAL; BioWhittaker, Emerainville,
France).
Cell cultures
The gene expression of the osteoblast has been shown to
depend on its maturation stage.17 The osteoblast maturation
can be evaluated through the production of alkaline phos-
phatase.18 Three types of osteoblast-like cell lines were used
spanning three different stages of osteoblast maturation. The
human MG-63 osteoblast-like cell (American Type Culture
Collection, Rockville, MD) can be considered as the least
mature osteoblast used in this study (alkaline phosphatase
activity: 2.7 U/g protein).19 The rat osteoblast, isolated in
our laboratory from neonatal Sprague-Dawley calvaria rat
following the procedure of Puelo,18 is an intermediate ma-
ture osteoblast (alkaline phosphatase activity: 60 U/g
protein; measurement performed in our laboratory using the
Diagnostic kit 245 of Sigma, St. Louis, MO). Finally, the hu-
man SaOS-2 osteoblast-like cell (American Type Culture
Collection) is the most mature osteoblast (alkaline phospha-
tase activity: 5264.4 U/g protein).19 The osteoblasts were
seeded at a concentration of 50,000 cells/cm2 in 50-mm petri
dishes and incubated for 4 h to allow cell adhesion. The
supernatant was removed, and 5 mL of particles solution
and normal medium was added, defining the time 0. Cell
samples were collected at 4 and 24 h for the gene expression
analysis, fibronetin (protein level), osteocalcin (protein level)
as well as alkaline phosphatase activity and at 24, 48, and 72
h for the apoptosis, Bcl2/Bax ratio, and caspase activity
quantification.
Confocal imaging (MG-63 osteoblast-like cells)
Cells were cultured 24 h with 0.1% Ti particles on cover-
slips. The cells were fixed 10 min in 4% paraformaldehyde
and washed in PBS. To visualize actin filaments, cells were
incubated for 1 h at 37°C with Alexa-488-conjugated phal-
loidin (Molecular Probes, Eugene, OR); tubulin was visual-
ized using anti-B-tubulin monoclonal antibody, followed by
incubation with an Alexa anti-mouse secondary antibody
(Molecular Probes) as previously described.20 Coverslips
were washed successively in PBS and deionized H2O for 5
min and mounted in Flouromount (Fisher, Santa Clara, CA).
Images were acquired using a confocal laser scanning mi-
croscope LSM 510 equipped with an argon laser module
(Carl Zeiss Inc., Thornwood, NY) using a 40× 1.3-na oil ob-
jective.
Measurement of DNA fragmentation as apoptosis
quantification (MG-63 osteoblast-like cells, rat
osteoblast, SaOS-2 osteoblast-like cells)
The internucleosomal cleavage of genomic DNA has been
demonstrated to be a hallmark of apoptosis.21 This was used
as quantification of osteoblast apoptosis. Before the analysis,
cells were fixed in ice-cold 30% ethanol and incubated with
100 g/mL of RNAse A and 50 g/mL propidium iodide
for 1 h at 37°C. FSC/SSC gateway was used to discriminate
between particles and cells. Hypodiploid cells were visual-
ized using a Becton-Dickinson FACScalibur and the pro-
gram ModFit LT 2.0 (Verity Software House, Topsham).
DNA fragmentation was assessed by flow cytometry.
Cellular assay for caspase activity (MG-63
osteoblast-like cells, rat osteoblast, SaOS-2
osteoblast-like cells)
At the indicated time points, cells were washed twice with
PBS, and the pellet was resuspended in caspase buffer (50
mM Hepes, pH 7.4, 100 mM NaCl, 1 mM EDTA, 0.1% Chaps,
and 5 mM dithiothreitol) for 30 min at 4°C. Lysates were
then stored at −80°C. The caspases enzymatic assays were
performed in 96-well plates. Lysates (10–20 g of total pro-
tein) were mixed with 50 L of caspase buffer, and reactions
were initiated by the addition of 100 M of the specific
substrate. After a 1-h incubation at 37°C, caspase-3-like pro-
tease activity was measured with the substrate Ac-DEVD-
AFC. Activity was measured by the release of 7-amino-4-
trifluoromethyl-coumarin (AFC) monitoring fluorescence at
excitation and emission wavelengths of 400 and 505 nm,
respectively.
Bcl2/Bax ratio (MG-63 osteoblast-like cells)
At the indicated time points, cells were washed twice with
PBS and lysed. Proteins were resolved by SDS-PAGE on a
4–20% Tris-Gly gel and transferred to a PVDF membrane.
The membrane was probed with specific antibodies against
Bcl-XL (mouse monoclonal clone 4; Transduction Lab), Bcl-2
(mouse monoclonal clone 7, Transduction Lab), Bax (rabbit
polyclonal; gift from J. Reed of The Burnham Research In-
stitute, San Diego, CA), and actin (mouse monoclonal,
Sigma). The bands were resolved with specific HRP-
conjugated secondary antibodies followed by enhanced che-
miluminescence (ECL; Amersham). The intensity of each
band was quantified by densitometry and compared with
the actin band. The intensity of each Bcl-2 family member
was then normalized to the control treated group (indicated
as 1) at each time point.
Analysis of gene expression (MG-63
osteoblast-like cells)
We used Genefilters (GF211; Research Genetics, Hunts-
ville, AL) and monitored the expression of approximately
4000 genes. The samples (5 g of total RNA per condition)
were processed according to the manufacturer’s recommen-
dations. A filter was used twice with the same sample in
order to verify the consistency of the results. There was good
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concordance between the two measurements. The data were
analyzed using the pathway software developed by Re-
search Genetics. Eighty genes were selected by fold modu-
lation over the control and were classified into eight groups
(extracellular matrix, cytokines, receptors, enzymes, nuclear
architecture regulation, cell adhesion, apoptosis, and oth-
ers).17,22,23 Three analyses were performed at 4 and 24 h:
control versus Ti, control versus PMMA, and Ti versus
PMMA. The difference in gene expression was based on our
experimental finding that genes had to be modulated at least
1.5- and 2.5-fold for the 4- and 24-h experiments, respec-
tively, to be significant in the assay used.
We tested the reliability of the Genefilters’ results by se-
lecting genes identified as being modulated significantly for
analysis and validation by quantitative real time RT-PCR
(TaqMan ABI Prism 7700; Applied Biosystem, Foster City,
CA). The GAPDH housekeeping gene was used to control
for input, thereby, allowing a comparison between samples.
Protein levels of fibronectin and osteocalcin and
alkaline phosphatase (ALP) activity (MG-63
osteoblast-like cells)
After a 4-h incubation, the supernatant was removed, and
the cells were washed three times with PBS. One milliliter of
particles solution (serum free) and medium (serum free) was
added defining the time 0. Supernatant and cell lysate (ob-
tained with 1% Triton-X) were collected at 4 and 24 h. The
lysate was sonicated for 30 s on ice. Before measuring, su-
pernatant and lysate were centrifuged at 800g for 2 min.
A volume of 100 L (respectively, 25 L) of supernatant of
the different samples was used to determine the level of
fibronectin (respectively, osteocalcin) with a commercial en-
zyme-linked immunoassay (Biomedical Technologies Inc.,
Stoughton, MA). In parallel, a volume of 2 L of lysate
sample was added to p-nitrophenyl phosphate solution
(Sigma) within a 96-well plate at 37°C for 3 min. p-
Nitrophenol is produced in the presence of ALP, and the
absorbance can be measured with a plate reader at 405 nm.
The change in rate of absorbance is directly proportional to
the activity of ALP. Data for fibronectin and osteonectin and
ALP activity were normalized by the total cell protein (DC
protein Assay Kit; Bio-Rad, Hercules, CA). Experiments
were performed in triplicate, and measurements were made
in duplicate.
RESULTS
Confocal imaging (MG-63 osteoblast-like cells)
The views of the MG-63 osteoblasts at different z-
levels clearly showed that the cytoplasm contained the
Ti particles, representing phagocytosis. A large num-
ber of particles were also found adjacent to the
nucleus (Fig. 2). Rhodamin-phalloidin staining
showed that the organization of the actin filaments
was profoundly altered when particles were present
(data not shown).
Apoptosis and caspase activity (MG-63
osteoblast-like cells, rat osteoblast, SaOS-2
osteoblast-like cells)
The particles induced apoptosis in osteoblast cells as
demonstrated by the appearance of hypodiploid
DNA-containing cells, which were measured by flow
cytometry in permeabilized cells stained with prop-
idium iodide (Fig. 3). The fluorometric measurement
of caspase-3-like activity using the synthetic substrate
Ac-DEVD-AFC confirmed the DNA content results
(Fig. 4). The Ti particles had the greatest effect upon
less mature MG-63 and mature SaOS-2 osteoblast-like
cells, whereas the rat osteoblasts appeared more resis-
tant. The PMMA particles were less potent to induce
apoptosis than the Ti particles. Control latex particles
did not induce apoptosis or caspase activity despite
being phagocytosed (results not shown).
Bcl2/Bax ratio (MG-63 osteoblast-like cells)
Different biological responses were observed be-
tween materials when expression of Bcl-2 family
members was monitored in particle-treated MG-63
cells (Fig. 5). Ti particles induced a slight downregu-
lation of the Bcl-XL levels after a 24-h incubation. Con-
versely, PMMA induced a strong induction of the Bcl-
XL levels that was prolonged up to 48 h postincuba-
tion, thus favoring survival. The Bcl-2 level also
changed when cells were incubated with Ti and
PMMA particles but its relative level of expression,
when compared with Bcl-XL, was much lower. Fi-
nally, Bax levels, although somewhat increased in
PMMA-treated cells at 24 h concomitantly to the Bcl-
XL and Bcl-2 increase, did not change dramatically
during the incubation period. It is conceivable that the
upregulation of the two anti-apoptotic proteins Bcl-XL
and Bcl-2 observed at 24 and 48 h in PMMA-treated
cells may be related to the delay in activation of
caspases.
Gene expression (MG-63 osteoblast-like cells)
Modulation of gene expression after a 4-h
co-incubation with Ti particles
After a 4-h co-incubation of Ti particles with MG-63
osteoblast-like cells, 853 genes of the 3964 queried had
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their expression modulated significantly. Of these, 32
were of the 80 initially selected genes. Twenty-one
genes were upregulated, and 11 were downregulated
in the Ti-treated group compared with the control
group. Little effect on the gene expression of extracel-
lular matrix proteins (type I collagen, osteonectin, os-
teopontin, and alkaline phosphatase) was observed,
except for an upregulation of the fibronectin and os-
teocalcin genes (Table I). The Ti particles had a strong
impact on cytokine gene expression with an upregu-
lation of the bone resorption inducers, interleukin 1
and 1,23 and TGF- (stimulates osteoblasts growth
and differentiation24), and a downregulation of fibro-
blast growth factor (promoter of osteoblast survival25)
gene (Table II). Gene expression for receptors of TNF
(bone resorption inducer23 and proapoptotic agent25),
interleukin 1 antagonist, insulin-like growth factor
(stimulates osteoblast proliferation and differentia-
tion26) and tyrosine-protein kinase (stimulate cellular
proliferation27) were downregulated, while TNF and
laminin receptor genes expression were upregulated
(Table III). A downregulation of the tissue inhibitor of
metalloproteinase (TIMP-1) gene expression was de-
tected (Table IV). This enzyme neutralizes the effect of
MMP-1, which can degrade type I collagen.28 In
conglomerate, the profile of genes modulated in
MG-63 osteoblasts in contact with Ti particles appears
to favor bone resorption. The Ti particles also had a
profound impact on the gene expression of proteins
that regulate the nuclear architecture (Table V).
Figure 2. MG-63 osteoblast-like cells were cultured 24 h with 0.1% Ti particles, cells were then fixed, and the cytoskeletal
alterations were visualized by staining with an antitubulin antibody (red, microtubules) and FITC-labeled phalloidin (green,
actin microfilaments). (a) Confocal fluorescence image showed the distribution of the actin microfilaments of a MG-63 cell.
Three dark spots at the center of the cell clearly show the lack of actin filaments in correspondence to the “ingested” Ti
particles. (b) Confocal fluorescence image shows the distribution of the microtubules of an MG-63 cell. The three bright red
spots at the center of the cells represent the Ti particles. (c) Nomarsky phase contrast image of the same cell demonstrates the
presence of the Ti particles ingested by the cell, indicated by the white arrows. (d) A combined image of the panels a, b, and
c illustrates the colocalization of the beads with the cytoskeletal alterations.
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An upregulation of the Pou and NuMA genes and a
downregulation of the HMG and SATB1 genes were
observed. These genes belong to the nuclear matrix
gene family.22 A downregulation was induced in the
actin-depolymerizing gene expression as well. The Ti
particles also modulated the expression of genes that
code for cell adhesion proteins with a downregulation
of the integrin 1 (21 is the major receptor for type I
collagen29) and an upregulation of laminin 1 (Table
VI). The apoptosis-related genes p53-binding protein
gene was upregulated, the anti- apoptotic Bcl-2 was
downregulated, possibly rendering the cells more
prone to undergo apoptotic cell death (Table VII). The
Ti particles had no effect on proliferation genes (c-fos,
c-myc, c-jun) (Table VIII).
Modulation of gene expression after 24 h
co-incubation with Ti particles
After a 24-h incubation of MG-63 osteoblast-like
cells with Ti particles, a less pronounced effect was
observed on gene modulation than at the 4-h time
point. Twenty-six genes of the 80 initially selected
genes had their expression modulated. Three genes
were upregulated, and 23 were downregulated in the
Ti group compared with the control group. For the
extracellular matrix protein group, no significant ef-
fect was observed except a downregulation of type XI
collagen (Table I). The largest difference in gene ex-
pression, as compared with the 4-h results, were
found in the cytokines group with a downregulation
of the macrophage-stimulating 1 and PDGF genes. A
strong downregulation of TGF- inducible early pro-
tein, and PDGF were also measured (Table II). Some
changes between the 4- and 24-h incubation were
found in the receptor group with a downregulation in
the gene expression of the receptors for interleukin 10,
colony-stimulating factor 3, TGF-, BMP type II, ste-
roid hormone, epidermal growth factor, and tyrosine-
protein kinase (Table III). MMP-7 gene expression was
also downregulated (Table IV) as well as the Pou and
Figure 3. Percentage of apoptotic cells in the three osteo-
blast-like cells used and with the two particle types tested.
Results are expressed as the means ± standard deviation
(error bars) and are representative of four independent ex-
periments. The Ti particles strongly induced apoptosis in the
MG-63 osteoblast-like cells, whereas the PMMA particles
had a less remarkable effect when compared with control.
This trend increased until 48 h of incubation, and then no
difference was found between the two types of particles and
the control. The induction of apoptosis by the particles was
less for the rat osteoblast than for the other cell types. Con-
trol cells presented a higher level of apoptotic cells than both
particle groups after 48 h of incubation. The Ti particle was
the only one to induce apoptosis in the SaOS-2 osteoblast-
like cells. Apoptosis increased with incubation time.
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YY1 genes (Table V). No differences with control were
observed for the expression of genes in the adhesion
group except for a downregulation of integrin M
(Table VI). For the apoptotic genes at 24 h, only BCL-2
was downregulated (Table VII). The proliferation gene
c-myc was downregulated as well as two heat shock
proteins (1 and 2), fast kinase, and serine/threonine
protein kinase SAK genes (Table VIII).
Comparison of gene modulation induced by Ti and
PPMA particles at both 4 and 24 h
After a 4-h incubation of MG-63 osteoblast-like cells
with PMMA and Ti particles, no modulation differ-
ence was observed except for the extracellular matrix
group. A downregulation was observed for TGF-,
TGF- receptor, steroid hormone receptor, tyrosine-
protein kinase receptor, YY1, BCL2, heat shock protein
Figure 5. Particle-induced modulation of Bcl-2 family
members expression for the MG-63 osteoblast-like cells.
Figure 4. Caspase-3-like activity for the three osteoblast
cell lines used and with the two particle types tested. Results
are expressed as the means ± standard deviation (error bars)
and are representative of four experiments. The caspase ac-
tivity of the MG-63 osteoblast-like cells in contact with
PMMA particles increased over time reaching a peak at 48 h
and then returned to its initial level. Unlike the PMMA par-
ticles, the Ti particles increased the caspase activity of osteo-
blasts up to the last timepoint of 72 h. The caspase activity of
the control group remained stable for the duration of the
experiment. The rat osteoblasts had a similar caspase activ-
ity for the two particles types with a constant increase over
time. The control group followed the same pattern with a
lower value of caspase activity. The caspase activity of
SaOS-2 cells peaked after 24 h and then decreased and re-
mained stable until 72 h. PMMA particles decreased the
caspase activity of SaOS-2 cells when compared with con-
trol. However, after 72 h of incubation, no difference were
found between the caspase activity of the SaOS-2 in contact
with the two particle types and the control group.
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TABLE I
Gene Name
C-Ti
4 h
C-PMMA
4 h
Ti-PMMA
4 h
C-Ti
24 h
C-PMMA
24 h
Ti-PMMA
24 h
Collagen, type I, alpha-2 +1.14 +1.10 −1.03 −1.91 −2.35 −1.25
Human pro-a2 chain of collagen type XI (COL11A2)
gene, complete cds −1.21 −1.37 −1.11 +3.06 +3.30 +1.07
Fibronectin 1 −1.58 −1.45 +1.04 +1.04 −1.09 −1.13
SPARC/osteonectin +1.29 −1.03 −1.32 −2.27 −2.47 −1.08
Secreted phosphoprotein 1 (osteopontin, bone
sialoprotein I) −1.35 −1.52 −1.12 −1.51 −1.38 +1.09
Biliary glycoprotein (BGP) (ostoecalcin) −1.52 −1.16 +1.3 +1.32 +2.39 +1.81
Alkaline phosphatase, liver/bond/kidney −1.19 +1.15 +1.37 +1.06 +1.17 +1.09
TABLE II
Gene Name
C-Ti
4 h
C-PMMA
4 h
Ti-PMMA
4 h
C-Ti
24 h
C-PMMA
24 h
Ti-PMMA
24 h
Homo sapiens TNF-related ligand TRANCE
mRNA, partial cds −1.17 −1.2 −1.03 +1.61 +2.66 +1.65
Bone morphogenetic protein 2 (BMP2) +1.31 (+1.61) +1.82 (+1.40) +1.39 +1.60 +2.09 +1.30
Transforming growth factor beta (BMP6) −1.30 −1.32 −1.01 −1.70 −2.02 −1.10
Transforming growth factor, beta 3 −1.97 −1.42 +1.38 +1.40 +1.70 +1.21
Human TGF-beta inducible early protein
(TIEG) mRNA, complete cds −1.86 (+1.11) −1.43 (−1.21) +1.30 +4.90 (+1.04) +5.28 (−2.95) +1.07
Macrophage stimulating 1 (hepatocyte growth
factor-like) −1.57 −1.91 −2.13 +3.0 +4.98 −1.22
Human PDGF associated protein mRNA,
complete cds −1.29 +1.04 +1.36 +4.02 +2.76 −1.45
Platelet-derived growth factor PDGF-A −1.75 −1.43 +1.22 +1.74 +1.44 −1.20
Interleukin 1  −1.59 −1.47 +1.08 −1.98 −1.45 +1.37
Interleukin 1  −1.56 −1.46 +1.07 −1.69 −1.32 +1.27
Interleukin-1  convertase precursor −1.30 −1.28 +1.01 +1.29 +1.34 +1.04
Interleukin 6 (B cell stimulatory factor 2) −1.12 −1.04 +1.11 −1.24 −1.37 −1.10
Fibroblast growth factor 7 (keratinocyte
growth factor) +1.51 +1.30 −1.13 −1.96 −1.64 +1.15
Granulocyte colony-stimulating factor
induced gene −1.0 −1.82 −1.80 −1.09 −1.66 −1.52
TABLE III
Gene Name
C-Ti
4 h
C-PMMA
4 h
Ti-PMMA
4 h
C-Ti
24 h
C-PMMA
24 h
Ti-PMMA
24 h
Interleukin 1 receptor antagonist −1.80 −2.10 −1.17 −1.90 −1.72 +1.10
Interleukin 4 receptor +1.10 −1.15 −1.28 −1.24 −1.33 −1.07
Interleukin 10 receptor +1.21 +1.50 +1.25 +3.46 +3.37 −1.02
Colony stimulating factor 3 receptor (granulocyte) +1.01 +1.32 +1.33 +4.05 +4.87 +1.2
Homo sapiens TNF receptor-1 associated protein
(TRADD) mRNA, 3 end of cds +1.5 −1.45 −2.16 −1.56 −2.74 −1.76
Human TNF receptor associated factor 6 (TRAF6)
mRNA, complete cds −1.35 −1.5 −1.09 −1.98 −2.08 −1.05
Prostaglandin E receptor 2 (subtype EP2), 53kD −1.40 −1.33 +1.06 +1.31 +1.08 −1.20
Transforming growth factor, beta receptor II (70–80 kD) −1.51 −1.01 +1.5 +4.06 +3.52 −1.15
Insulin-like growth factor 2 receptor −1.67 −2.15 −1.28 −1.4 −1.55 −1.10
Bone morphogenetic protein receptor, type II
(serine/threonine kinase) +1.42 +1.69 +1.19 +3.63 +3.16 −1.15
Steroid hormone receptor err1 −1.20 +1.58 +1.91 +3.71 +3.53 −1.05
1.05
Epidermal growth factor receptor −1.12 +1.26 +1.42 +3.18 +3.74 +1.17
Tyrosine-protein kinase receptor eph precursor −2.1 −1.40 +1.50 +4.87 +3.93 −1.24
Laminin receptor (2H5 epitope) +1.71 +1.02 −1.67 −1.65 −1.40 +1.18
Human clone pSK1 interferon gamma receptor
accessory factor-1 (AF-1) +1.32 +1.08 −1.22 −1.13 −1.9 −1.68
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TABLE IV
Gene Name
C-Ti
4 h
C-PMMA
4 h
Ti-PMMA
4 h
C-Ti
24 h
C-PMMA
24 h
Ti-PMMA
24 h
Matrix metalloproteinase 2 (gelatinase A; collagenase
type IV) (MMP2) −1.32 −1.25 −1.05 −1.56 +2.69 +1.72
Matrix metalloproteinase 7 (matrilysin, uterine) (MMP7) −1.26 −1.03 +1.21 +3.10 +5.00 +1.61
Matrix metalloproteinase 10 (stromelysin 2) (MMP10) −1.27 −1.3 −1.01 −1.82 −1.04 +1.73
Matrix metalloproteinase 13 (collagenase 3) (MMP13) −1.17 −1.45 −1.23 −1.76 −1.71 +1.03
TIMP1 +1.54 +1.20 −1.28 +1.06 −1.68 −1.78
tissue inhibitor of metalloproteinase 2 (TIMP2) +1.10 −1.18 −1.30 −1.32 −1.63 −1.23
TABLE V
Gene Name
C-Ti
4 h
C-PMMA
4 h
Ti-PMMA
4 h
C-Ti
24 h
C-PMMA
24 h
Ti-PMMA
24 h
Homo sapiens HMG box containing protein 1
mRNA, complete cds +1.58 +1.31 −1.20 −1.24 −2.13 −1.70
SATB1 +1.51 −1.06 −1.42 −1.60 −1.75 −1.09
POU homeobox protein −1.64 −1.11 +1.46 +4.03 +6.28 +1.55
Human YY1-associated factor 2 (YAF2) mRNA,
complete cds −1.36 +1.18 +1.62 +2.60 +3.05 +1.17
Clone PEBP2aA1) core-binding factor, runt domain,
alpha subunit 1 (CBFA1) −1.15 −1.63 −1.39 −2.40 −1.83 +1.31
H. sapiens NuMA gene (Clone T33) −1.52 +1.07 −1.41 −1.24 −1.36 +1.02
Lamin B receptor −1.79 −1.53 +1.16 −1.60 +1.00 +1.58
TABLE VI
Gene Name
C-Ti
4 h
C-PMMA
4 h
Ti-PMMA
4 h
C-Ti
24 h
C-PMMA
24 h
Ti-PMMA
24 h
Integrin, alpha 2 (CD49B,
alpha 2 subunit of VLA-2
receptor) +1.19 −1.24 −1.49 −1.36 −1.70 −1.24
Integrin, beta 1 +1.56 (+1.33) −1.3 (−1.28) −2.04 −1.19 (−2.12) −1.82 (+1.12) −1.53
Integrin, beta 3 (platelet
glycoprotein IIIa, antigen
CD61) +1.45 +1.06 −1.37 −1.17 +3.91 −2.01
Integrin, alpha 4 (antigen
CD49D, alpha 4 subunit of
VLA-4 receptor) −1.48 −1.30 +1.13 +1.22 +1.28 +1.04
Integrin, alpha V (vitronectin
receptor, alpha polypeptide,
antigen CD51) +1.04 −1.25 −1.3 +1.79 +1.26 −1.41
Integrin, alpha M (complement
component rece. 3, alpha;
CD11b (p170)) +1.26 +1.31 +1.04 +3.08 +2.20 −1.39
Integrin, alpha 7B −1.07 −1.28 −1.18 −1.07 −1.45 −1.36
Integrin beta-5 subunit +1.01 −1.1 −1.11 −1.71 −1.51 +1.12
Homo sapiens integrin
cytoplasmic domain
associated protein (Icap-1a) −1.02 +1.1 +1.12 −1.50 −1.31 +1.14
Human metalloprotease/
disintegrin/cysteine-rich
protein precursor (MDC9) +1.27 +1.20 −1.05 −1.87 −1.87 −1.00
Integrin, alpha E (antigen
CD103, human mucosal
lymphocyte antigen 1) −1.13 −1.05 +1.06 −2.12 −1.41 +1.50
Laminin, gamma 1 (formerly
LAMB2) −1.57 −1.51 +1.04 +1.25 +1.16 −1.07
Laminin, beta 2 (laminin S) −1.33 −1.74 −1.31 −1.67 −1.95 +1.04
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1, and serine/threonine protein kinase SAK gene ex-
pression. An upregulation of macrophage stimulating
1, granulocyte colony-stimulating factor, TNF receptor
1, lamin receptor, integrin 1, and c-fos genes expres-
sion was induced by the PMMA particles compared
with Ti. After 24 h of coincubation, there was no no-
ticeable difference in expression of the 80 selected
genes by the two types of particles.
Protein levels of fibronectin and osteocalcin and
alkaline phosphatase activity (MG-63
osteoblast-like cells)
A slight increase of fibronectin and osteocalcin pro-
duction by the Ti group at 4 h in comparison to control
at 4 h was observed corresponding to the Genefilters
results (Fig. 6). However, these differences were not
TABLE VII
Gene Name
C-Ti
4 h
C-PMMA
4 h
Ti-PMMA
4 h
C-Ti
24 h
C-PMMA
24 h
Ti-PMMA
24 h
Human Bcl-2 related (Bfl-1) mRNA,
complete cds +1.77 +3.02 +1.76 +3.21 +2.01 −1.59
Nucl. fact of kappa light polypeptide gene
enhancer in B-cells 1 (p105) (NF-) −1.43 (−1.88) −1.02 (−1.20) +1.40 −1.40 (−1.01) +1.00 (−1.12) +1.39
Mouse double minute 2, human homolog of;
p53-binding protein −1.67 −1.40 +1.19 −1.15 −1.02 +1.12
Hum cysteine protease CPP32 isoform alpha
mRNA, complete cds (caspase-3) −1.03 −1.15 −1.11 −1.00 −1.17 −1.18
TABLE VIII
Gene Name
C-Ti
4 h
C-PMMA
4 h
Ti-PMMA
4 h
C-Ti
24 h
C-PMMA
24 h
Ti-PMMA
24 h
Heat shock factor protein 2 −1.56 −1.52 +1.02 +4.63 +6.18 +1.33
Heat shock 760 kd protein
1
−1.41 +1.12 +1.59 +4.21 +4.21 −1.00
Transcription factor p65 −1.58 (−1.68) −1.48 (−1.47) +1.06 +3.18 (+1.03) +3.51 (−1.13) +1.10
H. sapiens mRNA for FAST
kinase
+1.22 +1.41 +1.15 +3.91 +3.51 −1.27
H. s. intermediate
conductance
calcium-activated
potassium channel
(hKCa4)
−1.36 +1.06 +1.44 +4.06 +5.26 +1.29
Homo sapiens mRNA for
serine/threonine protein
kinase SAK
−1.58 −1.03 +1.53 +4.08 +6.21 +1.52
Human protein kinase
(MLK-3) mRNA,
complete cds
+1.82 +2.09 +1.15 +4.36 +3.31 −1.31
40S ribosomal protein S15A +1.51 +1.50 −1.00 −2.65 −1.52 +1.71
Human NADH:ubiquinone
oxidoreductase MLRQ
subunit mRNA, complete
cds
+1.25 +1.45 +1.14 −2.84 −1.77 +1.60
H. sapiens RFXAP mRNA +1.12 −1.42 −1.60 −2.50 −1.75 +1.42
Human mRNA for c-myc
binding protein, complete
cds
−1.10 −1.32 −1.19 +2.64 +3.54 +1.34
P55-c-fos proton-oncogene
protein
−1.04 −1.59 −1.53 −1.50 −1.88 −1.25
Human c-jun proto
oncogene (JUN),
complete cds, clone hCJ-1
+1.05 −1.21 −1.28 +1.39 +1.45 +1.04
Capping protein (actin
filament), gelsolin-like
+1.42 +1.02 −1.39 −1.58 −1.57 +1.00
Actin depolymerizing factor
[human, fetal brain,
mRNA, 1452 nt]
+1.57 +1.73 +1.10 −1.62 −1.37 +1.18
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statistically significant. Indeed, no statistical difference
was observed between the groups for fibronectin and
osteocalcin production. Also, no statistical difference
was observed between all the samples for the ALP
activity, which followed the trend given by the Gen-
efilters results (Fig. 7).
DISCUSSION
The cells reaction to orthpedic implant particles has
been shown to be involved in implant loosening. Most
of the previous works studied the process of bone re-
sorption related to the presence of particles. Effects of
particles on bone formation have been negleted. In the
present study, we investigate the osteoblasts reaction
to Ti and PMMA particles.
Orthopedic implant particles induced apoptosis in
osteoblasts in our in vitro model system, and caspase-3
was involved in this process. This finding extends the
results obtained from previous studies with rat osteo-
blasts using the TUNEL assay.14 A higher percentage
of apoptosis induced by the particles was observed in
the MG-63 osteoblast-like cells. The increased suscep-
tibility to apoptosis of the less mature osteoblast could
have important consequences for bone remodeling. In-
deed, if less mature osteoblasts undergo apoptosis in
vivo as our results may indicate, the number of mature
osteoblasts that have to synthesize new bone will ob-
viously thereby decrease, favoring the resorption pro-
cess. Particle-induced apoptosis in osteoblast may
thus be partly responsible for the osteolysis surround-
ing orthopedic implants.
The apparent discrepancy between the levels of
caspase activity (Fig. 4) and the percentage of apop-
totic cells (Fig. 3) can be explained by the nature of the
assays. The percentage of apoptotic cells is a cumula-
tive measurement of cells currently undergoing apop-
tosis as well as cells that are dead but not completely
degraded. On the other hand, the measurement of
caspase activity is a snapshot of current enzymatic
activity, but the activated caspases will initiate a pro-
teolytic cascade that will eventually lead to their com-
plete cleavage and inactivation. At the protein level
using Western blot analysis, different biological re-
sponses were observed between materials when ex-
pression of Bcl-2 family members was monitored in
particle-treated MG-63 cells. The particles did alter the
relative levels of the Bcl-2 family members in the
treated cells, but the intensity of the changes do not
seem to be sufficient to explain the induction of an
apoptotic program.
Twelve of the 18 genes tested by real time RT-PCR
confirmed the results obtained in the cDNA Genefil-
ters. Differences may occur because cDNA microarray
does not discriminate between highly related genes
(>80% homology). In fact the signal of related genes
contribute in an additive manner to the measure-
ments. This is a limitation of the technology and why
validation by quantitative RT-PCR was performed.
Protein production of fibronectin by ELISA kit, osteo-
calcin by EIA kit, and alkaline phosphatase activity by
p-nitrophenyl phosphate solution gave trends similar
to the one observed with Genefilters.
Ti particles had a stronger effect on transcriptional
induction of genes than PMMA particles. This effect
could be partially explained by the slightly smaller
size distribution of the Ti particles compared with the
PMMA ones. It should be noted that the mean size of
Figure 6. Mean production ± SD (n = 3) of fibronectin (A) and osteocalcin (B) normalized by the total protein (TP) for MG-63
osteoblast-like cells. The differences were not statistically significant.
Figure 7. Mean ALP activity ± SD (n = 3) normalized by
the total protein (TP) for MG-63 osteoblast-like cells. The
differences were not statistically significant.
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the particles used in this study was larger than par-
ticles retrieved from peri-implant tissues obtained at
revision of failed prosthesis.30,31 Ninety percent of the
used Ti and PMMA particles had a diameter >10 m,
rendering phagocytosis by the cells difficult. There-
fore, it is possible that most of the effects quantified in
this study could be due more to cell-particle contact
than to phagocytosis. However, because of the large
distribution of particles size, it is difficult to draw a
definitive conclusion on the size effect in this study. A
minority of particles (smallest) could induce the most
stricking effect.
A profound effect of particles on genes that regulate
the nuclear and cell architecture was noted. This ob-
servation was confirmed by confocal imaging, which
demonstrated a reorganization of actin filaments
when particles were present. This effect on architec-
ture could be explained by particles being phagocy-
tosed by osteoblasts imposed deformations on the
cytoskeleton. These deformations can modulate the
expression of genes involved in controlling the archi-
tecture of the cell as described previously.32
The most striking effect of the particles was on the
modulation of cytokine genes, which was noticeable
after only 4 h of exposure of the cells to the particles.
It is difficult to interpret this effect on bone remodel-
ing. However, there was a trend toward downregula-
tion of cytokines or cytokine receptors involved in
bone formation (FGF, TIMP-1, ILGF) and an upregu-
lation of cytokines involved in bone resorption (IL-1,
IL-, TNF-). Thus, it is likely that the contact of par-
ticles with osteoblasts would favor the bone resorp-
tion in vivo.
Interestingly, this study showed that the expression
of the integrin 1, a major integrin responsible for os-
teoblast adhesion, was downregulated. Because osteo-
blasts are anchorage dependent cells, downregulation
of adhesion proteins can be responsible for cell dys-
function. Especially for less mature osteoblasts, it has
been shown that during early maturation the osteo-
blast adhesion proteins are usually upregulated.17 The
downregulation of integrin could explain our recent
finding that the adhesion strength of osteoblasts in
contact with particles was decreased.33 The succession
of events when osteoblasts are in contact with par-
ticles can therefore be proposed: osteoblast-particle
contact, phagocytosis of particles, decrease of cell ad-
hesion, and subsequent induction of apoptosis. How-
ever, this hypothetical schema needs further valida-
tion.
Our study demonstrates the undeniable impact of
orthopedic implant particles on osteoblasts. The peri-
implant osteolysis after a total joint replacement could
in part be attributed to a decrease of bone formation
and not only to an overstimulation of bone resorption
as it was generally believed. Consequently, develop-
ment of new drugs designed to control peri-implant
osteolysis should target the osteoblasts by promoting
their survival, increasing their adherence, favoring the
production of extracellular bone matrix, and decreas-
ing the synthesis of osteolytic cytokines.
The authors thank Davey Smith for critical review of this
manuscript.
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